U.S. flag

An official website of the United States government

NM_000027.4(AGA):c.365C>A (p.Thr122Lys) AND Aspartylglucosaminuria

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Jan 21, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000673721.11

Allele description [Variation Report for NM_000027.4(AGA):c.365C>A (p.Thr122Lys)]

NM_000027.4(AGA):c.365C>A (p.Thr122Lys)

Gene:
AGA:aspartylglucosaminidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q34.3
Genomic location:
Preferred name:
NM_000027.4(AGA):c.365C>A (p.Thr122Lys)
HGVS:
  • NC_000004.12:g.177439605G>T
  • NG_011845.2:g.7899C>A
  • NM_000027.4:c.365C>AMANE SELECT
  • NM_001171988.2:c.365C>A
  • NP_000018.2:p.Thr122Lys
  • NP_001165459.1:p.Thr122Lys
  • NC_000004.11:g.178360759G>T
  • NM_000027.3:c.365C>A
  • NR_033655.2:n.427C>A
Protein change:
T122K
Links:
dbSNP: rs771563230
NCBI 1000 Genomes Browser:
rs771563230
Molecular consequence:
  • NM_000027.4:c.365C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171988.2:c.365C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_033655.2:n.427C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Aspartylglucosaminuria (AGU)
Synonyms:
GLYCOASPARAGINASE; Aspartylglycosaminuria; Aspartylglucos-aminuria; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008830; MedGen: C0268225; Orphanet: 93; OMIM: 208400; Human Phenotype Ontology: HP:0012068

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002233214Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 30, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004214242Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 21, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Banning A, Gülec C, Rouvinen J, Gray SJ, Tikkanen R.

Sci Rep. 2016 Nov 23;6:37583. doi: 10.1038/srep37583.

PubMed [citation]
PMID:
27876883
PMCID:
PMC5120323

Optical coherence tomography features in brothers with aspartylglucosaminuria.

Goodspeed K, Harder L, Hughes S, Conger D, Taravella J, Gray SJ, Minassian B.

Ann Clin Transl Neurol. 2018 Dec;5(12):1622-1626. doi: 10.1002/acn3.672.

PubMed [citation]
PMID:
30564628
PMCID:
PMC6292186
See all PubMed Citations (4)

Details of each submission

From Counsyl, SCV000798956.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002233214.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Experimental studies have shown that this missense change affects AGA function (PMID: 27876883). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AGA protein function. ClinVar contains an entry for this variant (Variation ID: 557564). This missense change has been observed in individual(s) with aspartylglucosaminuria (PMID: 27876883, 30564628). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs771563230, gnomAD 0.0009%). This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 122 of the AGA protein (p.Thr122Lys).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004214242.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Flagged submissions

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000798956Counsyl
flagged submission
Reason: Claim with insufficient supporting evidence
Notes: None

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Apr 4, 2018)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Last Updated: Oct 20, 2024